You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Better health through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Should We Still be Performing Fetal Fibronectin Testing in the Clinical Lab?
What is the diagnosis?
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
Does Vitamin D Testing Add Value to Patient Care?
5/31/2011 8:46 AM |
Comments (2)
Recommend (1,058)
By
Ravinder Singh, PhD
In the US, millions of 25-OH-D tests have been performed in last few years. Testing has increased at the rate of 80% to 90% per year and has overwhelmed the clinical laboratories. Vitamin D deficiency is an important concern, but assays for serum 25-hydroxy vitamin D (25-OH-D), the accepted marker ...(
Read More
)
Posted at 5/31/2011 8:46 AM | Tags:
Diabetes/Endocrinology
"Lab Medicine for 2100" or "Watson, come quickly!"
5/24/2011 8:38 AM |
Comments (1)
Recommend (1,314)
By
Douglas F. Stickle, PhD
Many of you will have seen or heard of the recent appearance of IBM's Watson computer as a contestant on Jeopardy. The first show aired on February 14th, 2011 -- the 65th anniversary of the debut of ENIAC. The performance of Watson on Jeopardy was fantastic. The computational challenge was enormous...(
Read More
)
Posted at 5/24/2011 8:38 AM | Tags:
Instrumentation/Technology
|
Management/Medical Informatics
Is it Time to Apply Biological Variation in Thyroid Screening?
5/17/2011 8:35 AM |
Comments (2)
Recommend (1,009)
By
Martin Kroll, MD, FACB
Most clinicians rely on TSH to screen for thyroid disease, especially hypothyroidism (1). As the methods for TSH have improved, the number of cases with abnormal TSH values, but minimal symptoms has increased (2). Most physicians have relied on a TSH range of 0.3 to 5.0 mU/L; but the American Assoc...(
Read More
)
Posted at 5/17/2011 8:35 AM | Tags:
Diabetes/Endocrinology
Will a 15% Total Error Tolerance Be Safe and Effective for Hospital Use Glucose Meters?
5/10/2011 8:15 AM |
Comments (5)
Recommend (1,423)
By
Brad Karon, MD, PhD
Glucose meter accuracy criteria as defined in ISO 15197 (1) and CLSI guidelines require that for glucose values above 75 mg/dL, 95% of glucose meter results be within 20% of the reference glucose value. There has been growing momentum towards revision of these guidelines, primarily because of the c...(
Read More
)
Posted at 5/10/2011 8:15 AM | Tags:
Diabetes/Endocrinology
|
POC Testing
(Hidden) Admin Links
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093